![ATNT-01ABT-414 MONO- OR COMBINATION THERAPY WITH TEMOZOLOMIDE (TMZ) RECHALLENGE IN PATIENTS WITH RECURRENT GLIOBLASTOMA (GBM) AND AMPLIFIED EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR): A PHASE I STUDY]()
ATNT-01ABT-414 MONO- OR COMBINATION THERAPY WITH TEMOZOLOMIDE (TMZ) RECHALLENGE IN PATIENTS WITH RECURRENT GLIOBLASTOMA (GBM) AND AMPLIFIED EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR): A PHASE I STUDYGan, Hui K.; Kumthekar, Priya; Lassman, Andrew B.; Merrell, Ryan; van den Bent, Martin; Papadopoulos, Kyriakos P.; Scott, Andrew M.; Gomez, Erica; Fischer, JuDee; Mandich, Helen; Xiong, Hao; Lee, Ho-Jin; Munasinghe, Wijith; Roberts-Rapp, Lisa; Ansell, Peter; Holen, Kyle; Lai, Rose; Reardon, David A. · Neuro-Oncology · 2015